SEC Tracker
Get the app

Sionna Therapeutics SION

Rise Fund Sling II (Stockholder) plans to sell 54,333 SION shares, about $2.3M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jan 22, 2026
  2. Broker: Goldman Sachs & Co. LLC
  3. Shares acquired by: The shares of Common Stock reported herein were originally acquired by Seller upon the automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock

All of Rise Fund Sling II's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sionna Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025